Padeliporfin potassium by ImPact Biotech for Esophageal Cancer: Likelihood of Approval

Padeliporfin potassium is under clinical development by ImPact Biotech and currently in Phase I for Esophageal Cancer.

PF-08046054 by Pfizer for Melanoma: Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Melanoma.

February 21, 2024

Promoting Health Equity: A Guide for System-Involved Youth

Katie Renner Olse, Sr. Director at Sellers Dorsey All children deserve access to quality healthcare, including those involved with the foster care and juvenile justice

November 8, 2024

How dietary restrictions, including intermittent fasting, impact gut microbiota and overall human health

Preclinical and clinical data to analyze gut microbial alterations in various dietary conditions.

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.